As of 2025-09-18, the Relative Valuation of Precigen Inc (PGEN) is (6.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.82 USD, the upside of Precigen Inc based on Relative Valuation is -257.7%.
The range of the Relative Valuation is (4.83) - (6.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 22.3x | 18.1x |
| Forward P/E multiples | 13.8x - 19.4x | 16.6x |
| Fair Price | (4.83) - (6.74) | (6.03) |
| Upside | -226.4% - -276.4% | -257.7% |
| Date | P/E |
| 2025-09-17 | -11.00 |
| 2025-09-16 | -11.20 |
| 2025-09-15 | -10.34 |
| 2025-09-12 | -10.91 |
| 2025-09-11 | -11.92 |
| 2025-09-10 | -11.75 |
| 2025-09-09 | -11.89 |
| 2025-09-08 | -11.98 |
| 2025-09-05 | -12.56 |
| 2025-09-04 | -13.13 |
| 2025-09-03 | -13.68 |
| 2025-09-02 | -13.71 |
| 2025-08-29 | -12.99 |
| 2025-08-28 | -13.10 |
| 2025-08-27 | -13.22 |
| 2025-08-26 | -12.27 |
| 2025-08-25 | -11.46 |
| 2025-08-22 | -12.04 |
| 2025-08-21 | -10.48 |
| 2025-08-20 | -9.24 |
| 2025-08-19 | -9.27 |
| 2025-08-18 | -8.49 |
| 2025-08-15 | -8.47 |
| 2025-08-14 | -5.33 |
| 2025-08-13 | -5.50 |
| 2025-08-12 | -5.18 |
| 2025-08-11 | -5.01 |
| 2025-08-08 | -5.13 |
| 2025-08-07 | -5.41 |
| 2025-08-06 | -5.27 |
| 2025-08-05 | -5.56 |
| 2025-08-04 | -5.07 |
| 2025-08-01 | -4.81 |
| 2025-07-31 | -4.92 |
| 2025-07-30 | -4.98 |
| 2025-07-29 | -4.52 |
| 2025-07-28 | -4.55 |
| 2025-07-25 | -4.52 |
| 2025-07-24 | -4.61 |
| 2025-07-23 | -4.78 |
| 2025-07-22 | -4.38 |
| 2025-07-21 | -5.27 |
| 2025-07-18 | -5.07 |
| 2025-07-17 | -5.24 |
| 2025-07-16 | -5.30 |
| 2025-07-15 | -5.33 |
| 2025-07-14 | -5.62 |
| 2025-07-11 | -5.27 |
| 2025-07-10 | -5.50 |
| 2025-07-09 | -5.47 |